Latest Articles
Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer - Minichart
Karyopharm Therapeutics Reports Q1 2026 Results, Advances Selinexor Phase 3 Trials in Myelofibrosis and Endometrial Cancer Minichart
Published: May 14, 2026, 4:30 p.m.
Karyopharm completes endometrial cancer trial enrollment - Investing.com
Karyopharm completes endometrial cancer trial enrollment Investing.com
Published: May 14, 2026, 11:52 a.m.
Karyopharm completes endometrial cancer trial enrollment By Investing.com - Investing.com Canada
Karyopharm completes endometrial cancer trial enrollment By Investing.com Investing.com Canada
Published: May 14, 2026, 11:45 a.m.
Phase 3 endometrial cancer trial enrollment wraps as Q1 revenue hits $35.1M - Stock Titan
Phase 3 endometrial cancer trial enrollment wraps as Q1 revenue hits $35.1M Stock Titan
Published: May 14, 2026, 11:30 a.m.
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - PR Newswire
Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment PR Newswire
Published: May 14, 2026, 11:30 a.m.
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment - Moomoo
Press Release: Karyopharm Reports First Quarter 2026 Financial Results and Completion of Phase 3 Endometrial Cancer Trial Enrollment Moomoo
Published: May 14, 2026, 11:30 a.m.
Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial Cancer - OncLive
Emerging Clinical Trials and Future Therapeutic Strategies in Recurrent Endometrial Cancer OncLive
Published: May 14, 2026, 12:06 a.m.
Risks of gynecological and breast cancers in women with endometriosis or adenomyosis: A nationwide cohort study.
Endometriosis has been associated with several risk factors for cancer, and population-based research has shown that women with endometriosis have a higher risk of several types of cancer. The aim …
Published: May 14, 2026, midnight
UM research team identifies novel targeted therapy for endometrial cancer - University of Macau
UM research team identifies novel targeted therapy for endometrial cancer University of Macau
Published: May 13, 2026, 3:13 a.m.
Elevated CENPA Promotes Endometrial Cancer Progression - Docwire News
Elevated CENPA Promotes Endometrial Cancer Progression Docwire News
Published: May 12, 2026, 11:41 p.m.
Link copied to clipboard!